Akero Therapeutics, Inc. (AKRO) Social Stream



Akero Therapeutics, Inc. (AKRO): $10.18

0.03 (+0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AKRO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Akero Therapeutics Inc (AKRO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Akero Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 7 $64 $27 $48 $15.25 214.75%
2021-11-15 7 $62 $27 $47.714 $15.25 212.88%
2021-12-22 7 $62 $29 $47.571 $15.25 211.94%
2022-02-25 7 $62 $26 $47.142 $15.25 209.13%
2022-02-28 4 $62 $26 $46 $15.25 201.64%

The Trend in the Analyst Price Target


Over the past 45 weeks, AKRO's average price target has gone down $14.71.

Over the past 47 weeks, AKRO's average upside potential has been 136.64%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 3 81 46 60.71 28.64 111.98%
2021-07-17 3 82 46 60.86 22.33 172.55%
2021-08-07 8 68 46 57.33 20.47 180.07%
2021-09-20 8 65 40 54.71 23.24 135.41%
2021-10-19 7 64 27 48.00 21.45 123.78%

AKRO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 26 weeks, AKRO's average broker recommendation rating improved by 0.29.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AKRO as an investment opportunity.

  • In the context of all US stocks, Akero Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 713.72% of them.
  • AKRO has a lower variance in analysts' estimates than -574.88% of all US stocks.
  • In the context of stocks in the small market cap category, Akero Therapeutics Inc's average analyst price target is greater than 687.98% of them.
  • In the context of stocks in the small market cap category, Akero Therapeutics Inc's number of analysts covering the stock is higher than 618.47% of them.

In the Pharmaceutical Products industry, AKBA, AGLE, and AFMD are the three stocks most similar to Akero Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is AKRO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3938 seconds.